| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 09/06/2006 | CN1827147A Dispersible tablet with gastrodia tuber for treating headache, its preparation and quality control method |
| 09/06/2006 | CN1827107A Substained analgesia achieved with buprenorphine |
| 09/06/2006 | CN1827097A Application of crocin-A in brain protection |
| 09/06/2006 | CN1827095A Pharmaceutical composition using pregabalin as active ingredient, its preparation method and use |
| 09/06/2006 | CN1826923A Method for preparing brain-caring health-preserving instant soluble tea |
| 09/06/2006 | CN1826917A Health drink with milk and snow lotus live body and preparation method |
| 09/06/2006 | CN1273469C Tricyclic diazepines as tocolytic oxytocin receptor antagonists |
| 09/06/2006 | CN1273463C (1-phenacy-3-phenyl-3-piperidylethyl)piperidine derivatives, method for production thereof and pharmaceutical compositions containing the same |
| 09/06/2006 | CN1273460C Benzofuran and benzothiophene derivatives |
| 09/06/2006 | CN1273454C New pyrimidine-2,4,6-trione derivatives, processes for their production and pharmaceutical agents containing these compounds |
| 09/06/2006 | CN1273450C 1-aryl-or 1-alkylsulfonylbenzazole derivatives as 5-hydroxytryptamine-6ligands |
| 09/06/2006 | CN1273191C Method and composition for altering a B cell mediated pathology |
| 09/06/2006 | CN1273189C West nile vaccine |
| 09/06/2006 | CN1273156C Oral Chinese medicinal preparation for treating vascular dementia |
| 09/06/2006 | CN1273150C Medicine for treating depression and its preparing method |
| 09/06/2006 | CN1273143C Transdermal electrotransport device and method for manufacturing the same |
| 09/06/2006 | CN1273141C Oral pharmaceutical products containing 17beta-estradiol-3-lower alkanoate and preparation method thereof |
| 09/06/2006 | CN1273135C Pharmaceutical composition of N-methyl-D-aspartate receptor agonist |
| 09/06/2006 | CN1273131C Application of maltol in preparation of medicine for preventing and treating neuroretrogressive diseases |
| 09/06/2006 | CN1273129C Therapeutic compositions (II) |
| 09/06/2006 | CN1273127C Perfume compositions |
| 09/06/2006 | CN1273126C Compositions for regulating desire for smoking |
| 09/06/2006 | CN1273114C Sichuan aconite root freeze-dried powder injection and its preparing method |
| 09/06/2006 | CN1273110C System treatment of a mucosal surface |
| 09/06/2006 | CN1273030C Protein material for slow digestion and its use |
| 09/05/2006 | USRE39267 Thienopyrimidine-based inhibitors of the SRC family |
| 09/05/2006 | USRE39265 Heteroarylpiperidines, and their use as antipsychotics and analgetics |
| 09/05/2006 | US7102013 Treating under hydrolyzing conditions a hydantoin compound to form an alpha-amino acid derivative |
| 09/05/2006 | US7101974 Tumor necrosis factor ptotein; for use in the treatment of rheumatic diseases and arthritis |
| 09/05/2006 | US7101973 β-amyloid peptide-binding proteins and polynucleotides encoding the same |
| 09/05/2006 | US7101917 Mitochrondrial permeability transition pore affinity labels and modulators |
| 09/05/2006 | US7101912 when co-administered with levodopa in the colon of a patient is taken up at a much higher bioavailability than levodopa alone; treating Parkinson's disease or hypertension; dosage forms; sustained release; oral administration |
| 09/05/2006 | US7101911 Bis(substituted propynyl)-substituted benzenes, pyridines, pyrimidines, pyrazines, pyridines, furans and pyrroles; e.g., 3,5-bis-(3-(4-aminomethylbenzylaminocarbonyloxy)prop-1-ynyl)--1 -hydroxymethylbenzene |
| 09/05/2006 | US7101910 For therapy of insulin resistance syndrome, diabetes, hyperlipidemia, fatty liver disease, cachexia, obesity, atherosclerosis and arteriosclerosis |
| 09/05/2006 | US7101905 Pharmaceutically active compounds and methods of use |
| 09/05/2006 | US7101901 Treating Parkinson, Huntington's chorea, cerebral circulatory disorders, ischemia, cerebral ischemia, apoplexy, cerebral apoplexy, senile dementia, and Alzheimer's disease |
| 09/05/2006 | US7101896 Pharmaceutical compositions and methods for use |
| 09/05/2006 | US7101890 Benzazepine derivatives, drugs containing these and use of the same for producing drugs |
| 09/05/2006 | US7101887 Treating neuropsycological diseases; schizophrenia, psychotic depression and mania |
| 09/05/2006 | US7101886 such as N-{2-[2-(4-1,2-Benzisothiazol-3-yl-piperazin-1-yl)-ethyl]-phenyl}-2-(2,5-dimethoxy-phenyl)-acetamide; antagonists of dopamine D2 receptors and of serotonin 2A (5HT2a) receptors; for treatment of depression and dementia/schizophrenia |
| 09/05/2006 | US7101885 1-(4-Bromo-phenyl)-3-[2-(4-methyl-piperazin-1-yl)-pyridin-3-yloxy]-pyrrolidin-2-one; antagonists of the serotonin 5HT1B receptor; treating depression |
| 09/05/2006 | US7101883 Antiinflammatory agents, antiischemic agents, malaria, Crohn's disease, skin disorders |
| 09/05/2006 | US7101882 Morpholin-acetamide derivatives for the treatment of inflammatory diseases |
| 09/05/2006 | US7101881 N-(4-Chlorophenylacetyl)-8-(4-methylpiperazinyl)-tetrahydroisoquinoline; treating anxiety, depression, dysthymia, major depressive disorder, migraine, post-traumatic stress disorder, avoidant personality disorder, borderline personality disorder, phobias |
| 09/05/2006 | US7101877 Trans-[2-(4-Morpholinyl)-1-(2-Naphthenethoxy)]Cyclohexane Monohydrochloride; selectively inhibiting cardiac early repolarising currents and cardiac sodium currents |
| 09/05/2006 | US7101870 2R,3S) N1-[6,7-dihydro-5-(3-phenoxybenzyl)-6-oxo-5H-dibenz[b,d]azepin-7-yl]-2-(2-methylpropyl)-3-(propyl)-butanediamide; treating Alzheimer's disease and Down's Syndrome by inhibiting production of A beta -peptide |
| 09/05/2006 | US7101868 A 2-(((4-fluorophenyl)methyl)amino)-3-pyridinecarboxamide derivatives for treating cancer, angiogenesis, tumor |
| 09/05/2006 | US7101867 Benzofuran derivatives, their production and use |
| 09/05/2006 | US7101864 N-(2-acetamidoethyl)phosphonoformamide; inhibiting effect on zinc-containing proteinases, inhibiting cancer cells |
| 09/05/2006 | US7101861 For therapy and prophylaxis of host infected with flavivirus or pestivirus |
| 09/05/2006 | US7101860 Composition and method for inhibiting platelet aggregation |
| 09/05/2006 | US7101856 Thiophene glycoside derivatives, processes for the preparation, medicaments comprising these compounds, and the use thereof |
| 09/05/2006 | US7101851 IgE receptor antagonists |
| 09/05/2006 | US7101849 ωconotoxin peptides |
| 09/05/2006 | US7101666 Involvement of the BDNF gene in mood disorders |
| 09/05/2006 | US7101577 Extract of plant Dendrobii caulis and preparing process thereof |
| 09/05/2006 | US7101559 Immunomodulatory protein and useful embodiments thereof |
| 09/05/2006 | US7101550 Agents for modulating PD-1, B7-4, and the interaction between B7-4 and PD-1 in order to modulate a costimulatory or an inhibitory signal in a immune cell resulting in modulation of the immune response |
| 09/05/2006 | US7101548 Functional role of adrenomedullin (AM) and the gene-related product (PAMP) in human pathology and physiology |
| 09/05/2006 | CA2393640C Pyrrolo[2,3-d]pyrimidine compounds |
| 09/05/2006 | CA2259353C Plaster for the transdermal application of pergolide |
| 08/31/2006 | WO2006091988A1 Composition for treating mental health disorders |
| 08/31/2006 | WO2006091769A1 Novel quinoline derivatives as potassium ion channel openers |
| 08/31/2006 | WO2006091702A2 Multimediator dopamine transport inhibitors, and uses related thereto |
| 08/31/2006 | WO2006091592A1 Naphthalene derivatives as modulators of the glucocorticoid receptor |
| 08/31/2006 | WO2006091522A2 Methods for modulating macrophage proliferation in ocular disease using polyamine analogs |
| 08/31/2006 | WO2006091160A1 Diarylmethyl piperazine derivatives, preparations thereof and uses thereof |
| 08/31/2006 | WO2006090932A1 Surrogate marker for sulfonamide compound |
| 08/31/2006 | WO2006090927A1 Orexigenic action of sulfonamide compound |
| 08/31/2006 | WO2006090921A1 Inhibitory effect of sulfonamide compound on lymphocyte activation |
| 08/31/2006 | WO2006090910A1 Novel steroid glycoside, ngf-associated active substance, process for producing the same, method of screening thereof, and cerebral dysfunction preventive agent |
| 08/31/2006 | WO2006090850A1 Benzamide compound |
| 08/31/2006 | WO2006090830A1 Method of producing proanthocyanidin oligomer |
| 08/31/2006 | WO2006090759A1 Pharmaceutical agent comprising solifenacin |
| 08/31/2006 | WO2006090698A1 Kinase inhibitor and use thereof |
| 08/31/2006 | WO2006090616A1 Fat cell differentiation regulator |
| 08/31/2006 | WO2006090557A1 Preventive or therapeutic agent for stroke or sequelae of stroke comprising as main component salvianolic acid b or the like |
| 08/31/2006 | WO2006090555A1 Akt ACTIVATING AGENT |
| 08/31/2006 | WO2006090289A2 Compounds for reducing aggregation of amyloid beta-peptide |
| 08/31/2006 | WO2006090273A2 [1,8]naphthyridin-2-ones and related compounds with keto or hydroxyl linkers for the treatment of schizophrenia |
| 08/31/2006 | WO2006090272A1 Isoquinoline [1,8]naphthyridin-2-ones and related compounds for treatment of schizophrenia |
| 08/31/2006 | WO2006090263A1 Stable form i donepezil hydrochloride and process for its preparation and use in pharmaceutical compositions |
| 08/31/2006 | WO2006090224A1 Benzisoxazole derivatives |
| 08/31/2006 | WO2006090177A1 USE OF 2-(2-NITRO-4-TRIFLUOROMETHYLBENZOYL)-l,3- CYCLOHEXANEDIONE IN THE TREATMENT OF PARKINSON'S DISEASE |
| 08/31/2006 | WO2006090150A1 Pharmaceutical composition comprising amorphous rosiglitazone |
| 08/31/2006 | WO2006089973A2 Dosage form containing oxycodone and naloxone |
| 08/31/2006 | WO2006089874A1 Benzo[2,3]azepino[4,5-b]indol-6-ones |
| 08/31/2006 | WO2006089815A1 Novel pyrrolodihydroisoquinolines as pde10 inhibitors |
| 08/31/2006 | WO2006089700A1 Pyrrolidine and piperidine acetylene derivatives for use as mglur5 antagonists |
| 08/31/2006 | WO2006089658A2 Nk1 antagonists |
| 08/31/2006 | WO2006089586A1 Use of a compound with clusterin activity for the treatment of diseases associated with the deposition of abnormal proteins |
| 08/31/2006 | WO2006074940A3 Macrocyclic compounds and compositions useful as bace inhibitors |
| 08/31/2006 | WO2006074388A3 TRICYCLIC δ-OPIOID MODULATORS |
| 08/31/2006 | WO2006074025B1 Piperazinyl and piperidinyl ureas as modulators of fatty acid amide hydrolase |
| 08/31/2006 | WO2006059194A3 Pharmaceutical sustained-release composition containing clozapine |
| 08/31/2006 | WO2006053134A3 Deamidated interferon-beta |
| 08/31/2006 | WO2006038206A3 Compounds that modulate trh actions and inhibit the trh-degrading enzyme |
| 08/31/2006 | WO2006023852A3 Modulators of muscarinic receptors |
| 08/31/2006 | WO2006010969A8 New heterocyclic carboxylic acid amide derivatives |
| 08/31/2006 | WO2005111038A3 1h-indazoles, benzothiazoles, 1,2-benzoisoxazoles, 1,2-benzoisothiazoles, and chromones and preparation and uses thereof |